Aspen Aerogels Q2 EPS $(0.22) Beats $(0.36) Estimate, Sales $48.16M Miss $49.07M Estimate
Portfolio Pulse from vinayak@benzinga.com
Aspen Aerogels (NYSE:ASPN) reported Q2 losses of $(0.22) per share, beating the analyst consensus estimate of $(0.36) by 38.89%. However, the company's quarterly sales of $48.16 million missed the analyst consensus estimate of $49.07 million by 1.86%. This represents a 5.52% increase over sales from the same period last year.
August 04, 2023 | 12:24 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Aspen Aerogels reported better than expected Q2 EPS but missed on sales. This mixed report may lead to uncertain short-term price movement.
Aspen Aerogels reported a better than expected EPS, which is a positive signal for investors. However, the company missed on sales, which could be a concern. These mixed results may lead to uncertain short-term price movement.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100